Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Nuwellis, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q4 2021
- Shares held
- 780.8K
- −300.0K (−27.8%) vs. Q4 2021
- Total value
- $786.4K
- −$446.2K (−36.2%) vs. Q4 2021
- New holders
- 4
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUWE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $63.9K |
| Q1 2026 | 8 | $305.3K |
| Q4 2025 | 10 | $227.2K |
| Q3 2025 | 7 | $258.2K |
| Q2 2025 | 9 | $72.1K |
| Q1 2025 | 11 | $128.6K |
| Q4 2024 | 7 | $91.5K |
| Q3 2024 | 6 | $42.2K |
| Q2 2024 | 6 | $61.0K |
| Q1 2024 | 14 | $113.7K |
| Q4 2023 | 12 | $123.1K |
| Q3 2023 | 10 | $53.6K |
| Q2 2023 | 9 | $104.2K |
| Q1 2023 | 8 | $50.2K |
| Q4 2022 | 6 | $199.5K |
| Q3 2022 | 15 | $524.7K |
| Q2 2022 | 11 | $428.8K |
| Q1 2022 | 16 | $786.4K |
| Q4 2021 | 15 | $1.23M |
| Q3 2021 | 20 | $4.97M |
| Q2 2021 | 15 | $2.83M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Nuwellis, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bard Associates Inc | 442,818 | $447.0K | 0.16% | +16,000+3.7% | Added |
| Renaissance Technologies LLC | 182,600 | $184.0K | 0.00% | −23,000−11.2% | Reduced |
| Geode Capital Management, LLC | 43,819 | $44.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 22,200 | $22.0K | 0.00% | −20,600−48.1% | Reduced |
| Northern Trust Corp | 16,938 | $17.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 16,418 | $17.0K | 0.00% | +16,418 | New |
| State Street Corp | 14,505 | $15.0K | 0.00% | +605+4.4% | Added |
| Virtu Financial LLC | 12,190 | $12.0K | 0.00% | +12,190 | New |
| Tower Research Capital LLC (TRC) | 10,238 | $10.0K | 0.00% | +9,546+1,379.5% | Added |
| Goldman Sachs Group Inc | 10,001 | $10.0K | 0.00% | +10,001 | New |
| UBS Group AG | 4,922 | $5.00K | 0.00% | −8,758−64.0% | Reduced |
| JPMorgan Chase & Co | 2,442 | $2.00K | 0.00% | +176+7.8% | Added |
| Financial Perspectives, Inc | 1,345 | $1.36K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $0 | 0.00% | +39+63.9% | Added |
| Royal Bank of Canada | 225 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 14 | $0 | 0.00% | +14 | New |
| Vanguard Group Inc | 0 | $0 | 0.00% | −240,365−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −58,470−100.0% | Sold out |
| Searle & Co. | 0 | $0 | 0.00% | −13,750−100.0% | Sold out |